Login | Register
 Username 
 Password 
 
Login

HIV ATLAS

HIV :: TUBERCULOSIS :: MALARIA

Primary links

  • HOME
    • About Us
    • Contact Us
  • CLASSIFIED BLOGS
  • JOBS
  • EVENTS
  • LINKS
  • DAILY WIRE
  • VIDEOS
  |  
Home Blogs jenna's blog

Featured Jobs

  • Dean - Indian Institute of Advanced Nursing, Chennai
  • Research Capacity Building Advisor, Haiti
  • Vacancy announcement in Afghanistan
  • Chief of Party- Kenya Public Health
  • Chief of Party/Technical Advisor, HIV-Haiti
  • DEPUTY CHIEF OF PARTY, RUSSIA
  • CHIEF OF PARTY, RUSSIA
  • Chief of Party, India
  • Chief of Party- Kenya
  • Namibia Department of Defense Program Lead

Events

  • Media Outlets Interview Shah During Life Sciences Conference In Seattle
  • First summit of religious leaders on AIDS in Netherlands - Sify
  • Business leaders meet on HIV - Times LIVE
  • 11th International Workshop on Adverse Drug Reactions & Co-Morbidities in HIV Philadelphia, PA, USA, 28 October 2009 (AEGiS)
  • Aids in Culture VI: Explorations in the Cultural History of AIDS International Conference. Mexico City, 9 - 14 December 2010
  • Sexual Health Conference in Bali, May 4-6
  • CBCP calls for summit on HIV-AIDS - ABS CBN News
  • ASEAN youth meet to map out HIV/AIDS prevention activities - Xinhua
  • Gujarat - Get togehter 3000 PLHAs at Capital of Gujarat
  • International Symposium on HIV & Emerging Infectious Diseases.

Entrapment of multiple anti-Tb drugs in microemulsion system: Quantitative analysis, stability, and in vitro release studies.

Submitted by jenna on Tue, 11/10/2009 - 14:40
  • News-Tuberculosis
  • India

Entrapment of multiple anti-Tb drugs in microemulsion system: Quantitative analysis, stability, and in vitro release studies. - Related Articles
Entrapment of multiple anti-Tb drugs in microemulsion system: Quantitative analysis, stability, and in vitro release studies.
J Pharm Sci. 2009 Nov 5;
Authors: Mehta SK, Kaur G, Bhasin KK
The use of multiple drug regimes for the treatment of tuberculosis is restricted because of the degradation of Rifampicin in the presence of Isoniazid. In the present report, the microemulsion comprising Tween 80/ethanol/oleic acid/Buffer (pH 7.4) has been investigated for encapsulating Rifampicin (RIF), Isoniazid (INH), and Pyrazinamide (PZA) in different combinations. The main idea is to use the compartment of different domains of microemulsion for encapsulating drugs of different solubilties. The structural changes in the microstructure of microemulsion have been investigated in the light of the changes occurring in the presence of ATDs (anti-Tb drugs) in binary or ternary mixtures through conductivity and viscosity. Optical microscopy and (1)H NMR helped in estimating the shape and location of ATDs in microemulsion system. Electronic spectroscopy has been utilized qualitatively and quantitatively for understanding the stability and release of RIF from the composed formulation with various binary or ternary mixtures. Dissolution and release kinetics have been carried out to get an idea on the release of drugs from microemulsion formulation. ATDs in single and mixed drug formulations followed non-Fickian release behavior except for RIF in pH 7.4 release medium. The investigations employed have given us a fair success to predict not only the stability but also the release mechanism of ATDs in single and mixed drug formulations. (c) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci.
PMID: 19894276 [PubMed - as supplied by publisher]
[Tuberculosis Pulmonary]

  • jenna's blog
  • Login or register to post comments
  • Printer-friendly version

RESOURCES

  • AEGiS
  • AIDS.gov
  • AIDS_ASIA
  • AIDS-INDIA
  • AIDSPORTAL.org
  • About.com
  • Aids-write.org
  • All Africa.com
  • CDC
  • Children & HIV
  • Clinical Care Options HIV
  • DailyMed
  • EATG
  • EBLING LIBRARY
  • Eldis-Jobs
  • Eldis.org
  • GNP Latest news
  • Google-Homophobia
  • Google-HIV Baby-sitting
  • Google HIV NEWS
  • Google MALARIA NEWS
  • Google TB NEWS
  • HIV Law Project
  • HIV Positive Dating
  • HIV Twinning News
  • Hivdatfla
  • Hivsnp
  • IAVI
  • IFANET-INDIA
  • IGIB/CSIR
  • DevNetJobs
  • Indeed.com
  • Iran HIV AIDS
  • Juju-HIV
  • Kaiser-Child health
  • Kaiser HIV/AIDS
  • Kaiser Malaria
  • Kaiser-Tuberculosis
  • Kaiser-U.S. HIV
  • Medical News-HIV
  • Medical News-TB
  • MEDSCAPE
  • Medsin Manchester
  • National AIDS Map
  • Nature Jobs
  • Nets at Harvard University
  • NIAID
  • NMAC
  • NIH.gov
  • NMPrev
  • OpenSource.org.in
  • Oxfam Jobs
  • Partners Zambia
  • Policy and Ethics
  • PozHealth
  • PubMed-HIV
  • PubMed-Malaria
  • RBM Topline Stories
  • SAATHII
  • Save The Children
  • Treatment Action Campaign
  • Tuberculous-Meningitis
  • Tuberculosis-Pulmonary
  • UKLug-HIV
  • UKLug-Tuberculosis
  • UNAIDS-JOBS
  • UNAIDS-SERVICE
  • UNICEF News
  • UNICEF Photo Essays
  • WHO
  • Women & HIV
Every 9½ minutes someone in the US is infected with HIV. Act Against AIDS. Get the facts: NineAndaHalfMinutes.org

ABOUT HIV ATLAS

A Social Media initiative that aims to Collect, Collate, Classify and Disseminate the information on HIV, TB & Malaria so that people living with HIV and the people working in the field can be on top of the information generating from more than 700 online and offline resources.

HIV ATLAS provides its users a unique way to be on top of information ranging from common living to funding, jobs, events and much more absolutely free of charge. We encourage Employers to post their Job opportunities in our featured Jobs cateogry to reach out to more than 40000 subscribers daily.

JOIN HIV ATLAS

HIV ATLAS welcomes content contributions and strongly encourages all sector participants to actively share their advertisements.

You can contribute and engage by:
- Creating your profile
- Posting your classified advertisements
- sharing information about Jobs, Events, Funding etc with us
- sharing information about any online resource you want us to include
- creating your resume for potential employers to have a look in.

NEWLETTER SUBSCRIPTIONS

Manage your newsletter subscriptions
Select the newsletter(s) to which you want to subscribe or unsubscribe.
  Copyright © 2004-2009 HIV ATLAS.org. All rights reserved. | Legal | Contact Powered by Halosys Technologies Inc.  

Disclaimer: This site contains HIV prevention messages that may not be appropriate for all audiences.